Chemomab Therapeutics Ltd ADR (CMMB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -5,380 | N/A | -13,945 | N/A |
| Depreciation Amortization | N/A | 33 | N/A | 53 | N/A |
| Accounts receivable | N/A | 684 | N/A | -487 | N/A |
| Accounts payable and accrued liabilities | N/A | -288 | N/A | 150 | N/A |
| Other Working Capital | N/A | -1,007 | N/A | -2,111 | N/A |
| Other Operating Activity | 0 | -186 | 0 | 954 | 0 |
| Operating Cash Flow | $N/A | $-6,144 | $N/A | $-15,386 | $N/A |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | 2,297 | N/A |
| Other Investing Activity | 0 | 4,278 | 0 | 0 | 0 |
| Investing Cash Flow | $N/A | $4,278 | $N/A | $2,297 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,315 | N/A | 9,868 | N/A |
| Financing Cash Flow | $N/A | $1,315 | $N/A | $9,868 | $N/A |
| Beginning Cash Position | N/A | 6,147 | N/A | 9,368 | N/A |
| End Cash Position | N/A | 5,596 | N/A | 6,147 | N/A |
| Net Cash Flow | $N/A | $-551 | $N/A | $-3,221 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -6,144 | N/A | -15,386 | N/A |
| Free Cash Flow | 0 | -6,144 | 0 | -15,386 | 0 |